June 7, 2022 June 7, 2022Categories News StoriesPancreatic neuroendocrine tumors: Capecitabine plus temozolomide gives longer PFS than temozolomide alone
June 6, 2022 June 6, 2022Categories News StoriesNovel drug combination demonstrates promising results in treating pancreatic neuroendocrine tumors
June 6, 2022 June 6, 2022Categories News StoriesE2211: Dr. Pamela Kunz discusses the trial results and talks about the challenges of managing endocrine tumors
June 5, 2022 June 5, 2022Categories News StoriesDr. Pamela Kunz on pancreatic neuroendocrine tumors: A final analysis of temozolomide or temozolomide plus capecitabine
June 5, 2022 June 5, 2022Categories News StoriesDrug combination shows promise for treating pancreatic neuroendocrine tumors
May 27, 2022 May 27, 2022Categories Press ReleasesPress Release: ECOG-ACRIN research highlights at ASCO 2022
May 17, 2022 May 17, 2022Categories Press ReleasesMedia Advisory: ECOG-ACRIN data at ASCO will showcase the Group’s robust research portfolio
